个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共29条记录   A call for recognition of the medical physics profession [作者：Meghzifene, A,期刊：Lancet, 页码：1464-1465 , 文章类型： Editorial Material，,卷期：2012年379-9825] Physics and Medicine 4 Future medicine shaped by an interdisciplinary new biology [作者：O'Shea, P,期刊：Lancet, 页码：1544-1550 , 文章类型： Article，,卷期：2012年379-9825] The projected effects of the new biology on future medicine are described. The new biology is essentially the result of shifts in the way biological research has progressed over the past few years, mainly through the inv... Physics and Medicine 5 The importance of quantitative systemic thinking in medicine [作者：West, GB,期刊：Lancet, 页码：1551-1559 , 文章类型： Article，,卷期：2012年379-9825] The study and practice of medicine could benefit from an enhanced engagement with the new perspectives provided by the emerging areas of complexity science and systems biology. A more integrated, systemic approach is nee... Physics and medicine: a historical perspective [作者：Keevil, SF,期刊：Lancet, 页码：1517-1524 , 文章类型： Article，,卷期：2012年379-9825] Nowadays, the term medical physics usually refers to the work of physicists employed in hospitals, who are concerned mainly with medical applications of radiation, diagnostic imaging, and clinical measurement. This invol... Physics and medicine-two tips for a long and happy marriage [作者：Knight, P,期刊：Lancet, 页码：1463-1464 , 文章类型： Editorial Material，,卷期：2012年379-9825] Why we need a Commission on Global Governance for Health [作者：Estey, E,期刊：Lancet, 页码：1470-1471 , 文章类型： Editorial Material，,卷期：2012年379-9825] Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study [作者：Castaigne, S; Pautas, C; Terre, C; Raffoux, E; Bordessoule, D; Bastie, JN; Legrand, O; Thomas, X; Turlure, P; Reman, O; de Revel, T; Gastaud, L; de Gunzburg, N; Contentin, N; Henry, E; Marolleau, JP; Aljijakli, A; Rousselot, P; Fenaux, P; Preudhomme, C; Chevret, S; Dombret, H,期刊：Lancet, 页码：1508-1516 , 文章类型： Article，,卷期：2012年379-9825] Background The results of the addition of gemtuzumab ozogamicin, an anti-CD33 antibody conjugate, to the standard treatment for patients with acute myeloid leukaemia in phase 3 trials were contradictory. We investigated ... Promising new era dawns for cystic fibrosis treatment [作者：Corbyn, Z,期刊：Lancet, 页码：1475-1476 , 文章类型： Editorial Material，,卷期：2012年379-9825] End-stage kidney disease in the USA: possible solutions [作者：[Anonymous],期刊：Lancet, 页码：1461-1461 , 文章类型： Editorial Material，,卷期：2012年379-9825] Repeatedly red faced [作者：Rice, SA; Chee, R; Rustin, MHA,期刊：Lancet, 页码：1560-1560 , 文章类型： Editorial Material，,卷期：2012年379-9825] Rethinking dementia care in Australia [作者：[Anonymous],期刊：Lancet, 页码：1462-1462 , 文章类型： Editorial Material，,卷期：2012年379-9825] Bullying at Barts [作者：McDonald, S,期刊：Lancet, 页码：1483-1483 , 文章类型： Letter，,卷期：2012年379-9825] France's next president faces tough decisions on health [作者：Willsher, K,期刊：Lancet, 页码：1473-1474 , 文章类型： Editorial Material，,卷期：2012年379-9825]